School of Medicine
Showing 1-10 of 17 Results
-
Gillian Fell
Clinical Instructor, Surgery - Pediatric Surgery
BioGillian Fell, MD, PhD, is a pediatric surgeon and Clinical Instructor in the Division of Pediatric Surgery at Stanford University. Her clinical practice focuses on children and adolescents with intestinal failure and severe obesity. She works closely with multidisciplinary teams to provide comprehensive, family-centered care for these complex, long-term conditions.
Dr. Fell’s research investigates the mechanisms of hepatic fibrosis and regeneration. Her goals are to develop new therapies for chronic liver disease and non-invasive tools for detecting early fibrosis and tracking hepatic recovery. Her laboratory studies fibrosis using animal models, 3D microtissue platforms, and an IRB-approved bioregistry of liver biopsies from pediatric patients undergoing bariatric surgery. This work spans metabolic dysfunction-associated steatotic liver disease (MASLD), intestinal failure-associated liver disease (IFALD), and cholangiopathies such as primary biliary cholangitis and biliary atresia. Her work using 3D microtissue models to study fibrosis in primary biliary cholangitis is supported by the Gilead Research Scholars Program.
Dr. Fell is also Director of Research for the Stanford Pediatric and Adolescent Bariatric Surgery Program. With funding from the Stanford Maternal and Child Health Research Institute, she uses the PEDSnet database to identify predictors of optimal outcomes after bariatric surgery in children and adolescents. Before joining Stanford, she was an NIH F32-funded postdoctoral fellow in the laboratory of Dr. Mark Puder at Boston Children’s Hospital. There she studied parenteral nutrition-associated liver disease and helped develop novel intravenous lipid emulsions.
Dr. Fell received her MD from Harvard Medical School and her PhD from Harvard University. She completed her general surgery residency at Brigham and Women’s Hospital and her pediatric surgery fellowship at Children’s Hospital Los Angeles. -
Daniel James Firl
Clinical Instructor, Surgery - Abdominal Transplantation
BioDaniel Firl is an abdominal transplant surgery fellow at Stanford Medicine and a surgeon-scientist working at the intersection of hepatobiliary cancer surgery and transplantation. His work centers on patient selection in primary liver cancer — determining which patients are best served by resection and which by transplantation — and on the risk-assessment tools that make that decision more precise.
He is a co-developer of HALT-HCC, a risk model for liver transplantation in hepatocellular carcinoma, and first author of its international validation across more than 4,000 patients. His aim is to make selection between resection and transplantation progressively more sophisticated — sharpening prediction of waitlist and post-transplant outcomes, informing donor selection, and enabling the safe use of grafts that might otherwise be declined — with a particular interest in intrahepatic cholangiocarcinoma and gallbladder cancer, where the role of transplantation is still being defined. He sees the next step as the integration of tumor genomics, bringing the molecular features of each cancer into the models that guide surgical decisions.
Earlier, during postdoctoral training at the Massachusetts General Hospital, he studied the immunology and physiology of kidney xenotransplantation, including the design and long-term function of organs from genetically engineered porcine donors — part of the broader effort to expand the supply of transplantable organs.
Dr. Firl completed general surgery residency at Duke University, where he served as chief resident, and earned his MD with Special Qualifications in Biomedical Research through the research-intensive program at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He holds a bachelor's degree in biochemistry from Boston College.
He is the author of over 30 peer-reviewed articles, with work in Nature, Cell, The Lancet Gastroenterology & Hepatology, Hepatology, and The Lancet Digital Health. He serves as an ad hoc reviewer for journals including The BMJ, Kidney International, the American Journal of Transplantation, JCO Precision Oncology, and Transplantation.
He has received fellowships and grant funding from prestigious organizations during competitive funding opportunities including from: the NIH-NIAID, Howard Hughes Medical Institute, and the American Society of Transplantation.